IRIS
SALVATORE, DOMENICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.609
AS - Asia 5.495
EU - Europa 4.528
SA - Sud America 743
Continente sconosciuto - Info sul continente non disponibili 229
AF - Africa 189
OC - Oceania 5
AN - Antartide 1
Totale 16.799
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.357
SG - Singapore 2.508
RU - Federazione Russa 1.791
IT - Italia 1.263
CN - Cina 955
VN - Vietnam 955
BR - Brasile 604
HK - Hong Kong 477
DE - Germania 262
UA - Ucraina 238
FR - Francia 202
FI - Finlandia 174
NL - Olanda 171
CA - Canada 156
BD - Bangladesh 129
GB - Regno Unito 122
IN - India 104
JP - Giappone 79
AR - Argentina 61
CI - Costa d'Avorio 58
ZA - Sudafrica 55
IE - Irlanda 54
ES - Italia 46
PL - Polonia 44
MX - Messico 43
SE - Svezia 43
KR - Corea 38
IQ - Iraq 31
TR - Turchia 31
AT - Austria 29
PH - Filippine 28
ID - Indonesia 27
PK - Pakistan 19
TH - Thailandia 18
CO - Colombia 17
TW - Taiwan 17
BE - Belgio 16
EC - Ecuador 16
NG - Nigeria 15
JM - Giamaica 14
SA - Arabia Saudita 12
UZ - Uzbekistan 12
VE - Venezuela 12
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
CZ - Repubblica Ceca 9
DZ - Algeria 9
HN - Honduras 9
MA - Marocco 9
MY - Malesia 9
KE - Kenya 8
LT - Lituania 8
SK - Slovacchia (Repubblica Slovacca) 8
EG - Egitto 7
SN - Senegal 7
BG - Bulgaria 6
CH - Svizzera 6
JO - Giordania 6
PE - Perù 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
BO - Bolivia 5
CL - Cile 5
CR - Costa Rica 5
DK - Danimarca 5
NP - Nepal 5
PT - Portogallo 5
TN - Tunisia 5
GT - Guatemala 4
AL - Albania 3
AU - Australia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
EU - Europa 3
HU - Ungheria 3
IL - Israele 3
KW - Kuwait 3
NI - Nicaragua 3
RO - Romania 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CG - Congo 2
GR - Grecia 2
IR - Iran 2
KG - Kirghizistan 2
MD - Moldavia 2
MN - Mongolia 2
MU - Mauritius 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AQ - Antartide 1
BF - Burkina Faso 1
Totale 16.552
Salva come PNG Salva come JPEG
Città #
Singapore 1.149
San Jose 915
Ashburn 467
Hong Kong 459
Moscow 428
Naples 406
Ho Chi Minh City 290
Chandler 284
Beijing 269
Jacksonville 219
Hanoi 207
Santa Clara 189
Council Bluffs 162
Amsterdam 139
Hefei 135
Los Angeles 132
Lauterbourg 127
Millbury 116
The Dalles 96
Napoli 95
Boston 94
New York 92
Princeton 86
Munich 78
Buffalo 77
Wilmington 63
São Paulo 62
Phoenix 57
Tokyo 57
Nanjing 56
Dallas 50
Haiphong 48
Turku 48
Ottawa 46
Orem 45
Redondo Beach 44
Lawrence 42
Des Moines 38
Rome 37
Houston 36
Milan 35
Warsaw 34
Montreal 33
Da Nang 32
Brooklyn 31
Chicago 31
Nuremberg 30
Toronto 29
Helsinki 27
Johannesburg 26
Seattle 26
Frankfurt am Main 24
Norwalk 24
Salerno 24
Seoul 24
Stockholm 24
Kochi 23
Denver 22
Poplar 22
Atlanta 20
Chennai 20
Hebei 20
Mexico City 20
Shenyang 20
San Giovanni Rotondo 19
Nanchang 17
Rio de Janeiro 17
Belo Horizonte 16
Dong Ket 16
San Francisco 15
Washington 15
Abuja 14
Afragola 14
London 14
Thái Nguyên 14
Ann Arbor 13
Florence 13
Santa Maria 13
Santa Maria Capua Vetere 13
Tianjin 13
Boardman 12
Curitiba 12
Lappeenranta 12
Okayama 12
Ottaviano 12
Vienna 12
Can Tho 11
Changsha 11
Hải Dương 11
Shanghai 11
Thái Bình 11
Aversa 10
Biên Hòa 10
Brasília 10
Charlotte 10
Tashkent 10
Woodbridge 10
Avellino 9
Bangkok 9
Casoria 9
Totale 8.511
Salva come PNG Salva come JPEG
Nome #
Germ Line Mutations in the Thyroid Hormone Receptor Alpha Gene Predispose to Cutaneous Tags and Melanocytic Nevi 263
Spot-light on microbiota in obesity and cancer 216
The thyroid hormone activating enzyme, type 2 deiodinase, induces myogenic differentiation by regulating mitochondrial metabolism and reducing oxidative stress 203
Thyroid hormone induces progression and invasiveness of squamous cell carcinomas by promoting a ZEB-1/E-cadherin switch 203
Exposure to artificial light at night: A common link for obesity and cancer? 197
The Concerted Action of Type 2 and Type 3 Deiodinases Regulates the Cell Cycle and Survival of Basal Cell Carcinoma Cells 192
Loss of p53 activates thyroid hormone via type 2 deiodinase and enhances DNA damage 191
Reciprocal interplay between thyroid hormone and microRNA-21 regulates hedgehog pathway-driven skin tumorigenesis 190
D898_E901 RET Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms 184
Activated Thyroid Hormone Promotes Differentiation and Chemotherapeutic Sensitization of Colorectal Cancer Stem Cells by Regulating Wnt and BMP4 Signaling 181
Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone 180
Deiodinases and their intricate role in thyroid hormone homeostasis 176
Vandetanib downregulates type 2 deiodinase in fibro/adipogenic progenitors 174
Thyroid hormone enhances angiogenesis and the warburg effect in squamous cell carcinomas 173
Type 2 Deiodinase Promotes Fatty Adipogenesis in Muscle Fibroadipogenic Progenitors From Adult Male Mice 171
Type 2 deiodinase is expressed in anaplastic thyroid carcinoma and its inhibition causes cell senescence 165
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients 165
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 162
Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report 161
Beta-Catenin Regulates Deiodinase Levels and Thyroid Hormone Signaling in Colon Cancer Cells 159
DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients 159
Long-term management of lenvatinib-treated thyroid cancer patients: a real-life experience at a single institution 158
Calcium interaction with bovine Thyroglobulin: Stoichiometry and structural consequences of calcium binding. 154
Author Correction: Thyroid hormone induces progression and invasiveness of squamous cell carcinomas by promoting a ZEB-1/E-cadherin switch (Nature Communications, (2019), 10, 1, (5410), 10.1038/s41467-019-13140-2) 151
Activation and inactivation of thyroid hormone by deiodinases: local action with general consequences 147
Imaging medullary thyroid cancer patients with detectable serum markers: state of the art and future perspectives 147
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 144
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 142
FT3 and FT3/FT4 ratio are decreased and not compensated by levothyroxine treatment in TKI-treated thyroid cancer patients 136
Advances in functional imaging of differentiated thyroid cancer 136
Thyroid hormone signaling and deiodinase actions in muscle stem/progenitor cells 135
Long-term prognostic value of the response to therapy assessed by laboratory and imaging findings in patients with differentiated thyroid cancer 134
A Type 2 Deiodinase-Dependent Increase in Vegfa Mediates Myoblast-Endothelial Cell Crosstalk during Skeletal Muscle Regeneration 133
Treatment of Cutaneous Melanoma Harboring SMO p.Gln216Arg Mutation with Imiquimod: An Old Drug with New Results 132
Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. 132
Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy 131
Management of one patient with oligoprogressive thyroid cancer during treatment with lenvatinib 131
Missense mutation in the transcription factor NKX2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis 130
Deiodinases: the balance of thyroid hormone: local impact of thyroid hormone inactivation 130
Intracellular inactivation of thyroid hormone is a survival mechanism for muscle stem cell proliferation and lineage progression 130
Identification and functional characterization of a novel mutation in the NKX2-1 gene: Comparison with the data in the literature 130
Elexacaftor–tezacaftor–ivacaftor therapy for cystic fibrosis patients with the f508del/unknown genotype 130
The different cardiac expression of the type 2 iodothyronine deiodinase gene between human and rat is related to the differential response of the Dio2 genes to Nkx-2.5 and GATA-4 transcription factors. 129
Type 3 deiodinase and solid tumors: an intriguing pair. 128
Methods and Products for Treating Proliferative Disorders. 128
Thyroid hormone action in muscle atrophy 128
Mice with hepatocyte-specific deficiency of type 3 deiodinase have intact liver regeneration and accelerated recovery from nonthyroidal illness after toxin-induced hepatonecrosis. 127
Local ablative therapy of oligoprogressive TKI-treated thyroid cancer 127
Identification and Functional Characterization of a Novel Mutation in theNKX2-1Gene: Comparison with the Data in the Literature 126
Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer? 125
Calcium interaction with bovine thyroiglobulin: stoichiometry and structural consequences of calcium binding 124
A Global Loss of Dio2 Leads to Unexpected Changes in Function and Fiber Types of Slow Skeletal Muscle in Male Mice 123
Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic 123
Endemic goiter and iodine deficiency diffusion in province of Avellino 121
Epigenetic control of type 2 and 3 deiodinases in myogenesis: role of Lysine-specific Demethylase enzyme and FoxO3 121
Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins. 120
The relevance of T3 in the management of hypothyroidism 120
Evaluating local thyroid cytopathology practices by molecular quality metrics: A multi‐institutional study on 4651 FNAs with a focus on the role of the interventional cytopathologist 120
Teriparatide replacement therapy for hypoparathyroidism during treatment with lenvatinib for advanced thyroid cancer: A case report 118
Transcription factor Nkx-2.5 induces sodium/iodidesymporter gene expression and participates in retinoic acid- andlactation-induced transcription in mammary cells. 117
Widespread endemic goiter and iodine deficiency in the province of Avellino 117
The importance of the RET gene in thyroid cancer and therapeutic implications 116
The different cardiac expression of the Type 2 Iodothyronine deiodinase gene between human and rat is related to the differential response of the dio2 genes to NKX-2.5 and GATA-4 transcription factors 115
Tiroide è Donna 112
Deiodinases in thyroid tumorigenesis 112
Deiodinases and Cancer 111
The selective loss of the Type 2 iodothyronine deiodinase in mouse thyrotrophs increases basal TSH but blunts the thyrotropin response to hypothyroidism 111
p63 control of desmosome gene expression and adhesion is compromised in AEC syndrome 110
Role of type 3 deiodinase in cancer. 108
Thyroid Hormone Hyposensitivity: From Genotype to Phenotype and Back 108
On the governance of incentives to innovate: Can Open Source models be applied to drug development? 107
Targeting the right population for T3 + T4 combined therapy: where are we now and where to next? 106
CHERACTERIZATION OF THE 5'-FLANKING AND 5'UNTRANSLATED REGIONS OF THE CYCLIC ADENOSINE 3',5'-MONOPHOSPHATE-RESPONSIVE HUMAN TYPE 2 DEIODINASE GENE. 105
The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration. 105
APPROCCIO CLINICO AL PAZIENTE CON GOZZO 103
Point mutation of the RET proto-oncogene in the TT human medullary thyroid carcinoma cell line. 103
Consumptive hypothyroidism resulting from hepatic vascular tumors in an athyreotic adult. 103
The unique signature of tyrosine kinase inhibitor-induced hypothyroidism 102
Safety and Quality-of-Life Data from an Italian Expanded Access Program of Lenvatinib for Treatment of Thyroid Cancer 102
A 21 year old woman with consumptive hypothyroidism due to a vascular tumor expressing type 3 iodothyronine deiodinase 102
PTC IN THYROID TUMORS 100
Effectivenesss of ivacaftor in severe cystic fibrosis patients and non-G551D gating mutations 100
Pendrin is a Novel In Vivo Downstream Target Gene of the TTF-1/Nkx-2.1 Homeodomain Transcription Factor in Differentiated Thyroid Cells 100
Development of thyroid papillary carcinomas secondary to tissue specific expression of the RET/PTC1 oncogene in transgenic mice 99
Enhanced adrenal renin and aldosterone biosynthesis during sodium restriction in TGR (mREN2)27 rats 99
Type 2 Iodothyronine Deiodinase Levels Are Higher in Slow-Twitch than Fast-Twitch Mouse Skeletal Muscle and Are Increased in Hypothyroidism 99
Biochemistry, cellular and molecular biology, and physiological role of the iodothyronine selenodeiodinases 98
Type II iodothyronine deiodinase provides intracellular 3,5,3'-triiodothyronine to normal and regenerating mouse skeletal muscle 98
CLONING OF THE RAT TISSUE INHIBITOR OF METALLOPROTEINASE TYPE 2 (timp-2) GENE; ANALYSIS OF ITSEXPRESSION IN NORMAL AND TRASFORMED THYROID CELLS. 97
Cloning of the rat tissue inhibitor of metalloproteinases type 2 (TIMP-2) gene: analysis of its expression in normal and transformed thyroid cells. 96
Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene. 96
Clinical outcomes of a large cohort of individuals with the F508del/5T;TG12 CFTR genotype 96
FREQUENT RET PROTO-ONCOGENE MUTATIONS IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A (MEN2A). 95
RET\PTC activation in human thyroid carcinomas 95
8th edition of the AJCC/TNM staging system of thyroid cancer: What to expect (ITCO#2) 95
Deiodination in cancer growth: the role of type III deiodinase 94
INCREASED IN-VIVO PHOSPHORILATION OF RET TYROSINE 1062 IS A POTENTIAL PATHOGENETIC MECHANISM OF MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B. 93
MUTATION OF SECYS RESIDUE 266 IN HUMAN D2 SELENODEIODINASE ALTERS 75Se INCORPORATION WITHOUT AFFECTING THE BIOCHEMICAL PROPERTIES. 90
MOLECULAR BIOLOGICAL AND BIOCHEMICAL CHARACTERIZATION OF THE HUMAN TYPE 2 SELENODEIODINASE. 89
Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B. 89
Totale 13.059
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.831
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.831
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022828 0 0 33 24 26 14 36 29 74 63 235 294
2022/2023906 138 76 24 34 88 80 7 62 143 138 61 55
2023/2024868 54 137 154 83 49 72 16 80 26 18 116 63
2024/20254.232 215 264 34 40 111 248 471 243 312 433 1.455 406
2025/20267.699 920 503 770 824 1.266 345 863 420 855 473 228 232
2026/2027741 262 298 181 0 0 0 0 0 0 0 0 0
Totale 16.799